 |
|
|
| |
Short Duration Treatment with AL-335 and Odalasvir, with or without Simeprevir, in Treatment Naïve Patients with Hepatitis C Infection with or without Cirrhosis
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-22 Amsterdam Netherlands
Ed Gane,1 Catherine Stedman,2 Matthew McClure,3 David Apelian,4 Chris Westland,3 Jennifer Vuong,3 Megha Patel,3 Thomas Kakuda,3 Sushmita Chanda,3 Lawrence Blatt,3 Leo Beigelman,3 David Smith,3 John Fry3
1University of Auckland, Auckland, New Zealand; 2University of Otago, Christchurch, New Zealand; 3Alios BioPharma Inc., part of the Janssen Pharmaceutical Companies, South San Francisco, CA, USA; 4Achillion, New Haven, CT, USA
|
| |
|
|
|
|
|
